Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study
Ultrasound in Obstetrics & Gynecology · 2025-04 · 65 (4) · 462-469
DOI: 10.1002/uog.29198 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Ultrasound in Obstetrics & Gynecology, online erschienen am 27.02.2025. Verfasst von K Gadsbøll und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal Medicine, Pregnancy and Ultrasound, Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospital…. Hauptthemen laut MEDLINE: Nuchal Translucency Measurement, Karyotyping, Chromosome Aberrations, Chromosome Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Objective
To assess the outcome of pregnancies with increased fetal nuchal translucency (NT) thickness and a normal result from chromosomal microarray (CMA) vs conventional karyotyping.
Methods
This was a Danish nationwide registry‐based cohort study of all singleton pregnancies seen for combined first‐trimester screening between 2008 and 2018. Data on NT thickness and pregnancy outcome were retrieved from the Danish Fetal Medicine Database, whereas data on cytogenetic and molecular karyotypes were retrieved from the Danish Cytogenetic Central Register. Pregnancies were stratified according to NT thickness, and we computed the prevalence of chromosomal aberration, termination of pregnancy (due to non‐genetic abnormal findings aside from increased NT), pregnancy loss, major congenital malformation and unaffected live birth (live birth ≥ 24 weeks' gestation with no chromosomal aberration or major congenital malformation diagnosed). The prevalence of the different outcomes was further estimated for pregnancies with increased NT (≥ 3.5 mm) and a normal CMA result. Finally, to assess the impact of CMA compared with conventional karyotyping for increased NT, we compared the prevalence of chromosomal aberrations and each pregnancy outcome between the periods 2008–2012 and 2014–2018 (during which < 3% and > 60%, respectively, of pregnancies with increased NT were examined using CMA).
Results
We identified 557 896 pregnancies with a NT measurement for which outcome data were registered. Fetal NT was ≥ 3.5 mm in 3717 (0.7%) pregnancies, of which 3368 (91%) underwent genetic examination. The prevalence of chromosomal aberrations increased significantly with increasing NT thickness, from 21% in pregnancies with NT of 3.5–4.4 mm to 69% in pregnancies with NT ≥ 6.5 mm. Trisomies 21, 18 and 13 accounted for the majority of chromosomal aberrations diagnosed in all subgroups of increased NT (range, 61–87%). In pregnancies with increased NT and a normal CMA result, the prevalence of unaffected live birth decreased significantly from 87% for NT of 3.5–4.4 mm to 29% for NT ≥ 6.5 mm. Increased uptake of CMA during 2014–2018 compared with 2008–2012 slightly increased the detection of submicroscopic aberrations. However, a normal CMA result, compared with a normal result from conventional karyotyping, did not substantially improve the prognosis in pregnancies with increased NT.
Conclusions
Our study reaffirms the association between increased NT and chromosomal aberrations. Although CMA improves diagnostic resolution in pregnancies with increased NT, a normal test result does not substantially impact the prevalence of unaffected live births. This highlights the ongoing need for accurate clinical guidance and continued research, especially as whole‐genome sequencing is increasingly adopted in prenatal care. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Fetal Medicine, Pregnancy and Ultrasound, Department of Gynecology, Fertility and Obstetrics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
- Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
- Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark.
- Department of Obstetrics and Gynecology, Center for Fetal Medicine, Aarhus University Hospital, Aarhus, Denmark.
- Center for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
ORCID-Profile: K Gadsbøll, N Brix, P Sandager, O B Petersen, A P Souka, K H Nicolaides, I Vogel
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Gadsbøll, K., Brix, N., Sandager, P., Petersen, O. B., Souka, A. P., Nicolaides, K. H., & Vogel, I. (2025). Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study. Ultrasound in Obstetrics & Gynecology, 65(4), 462-469. https://doi.org/10.1002/uog.29198
Vancouver
Gadsbøll K, Brix N, Sandager P, Petersen OB, Souka AP, Nicolaides KH, et al. Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study. Ultrasound in Obstetrics & Gynecology. 2025;65(4):462-469. doi:10.1002/uog.29198
BibTeX
@article{Gadsbll2025,
author = {Gadsbøll, K and Brix, N and Sandager, P and Petersen, O B and Souka, A P and Nicolaides, K H and Vogel, I},
title = {Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study},
journal = {Ultrasound in Obstetrics & Gynecology},
year = {2025},
volume = {65},
number = {4},
pages = {462--469},
doi = {10.1002/uog.29198}
}
EUVIMED